NCT00859183View on ClinicalTrials.gov

Oral Sirolimus for In-Stent Restenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2004

Conditions
Coronary Restenosis
Interventions
DRUG

Sirolimus

cumulative loading dose of 8 mg of oral sirolimus two days prior to and the day of repeat intervention followed by maintenance therapy of 2 mg/day for 7 days

DRUG

Sirolimus

cumulative loading dose of 24 mg of oral sirolimus two days prior to and the day of repeat intervention followed by maintenance therapy of 2 mg/day for 7 days

DRUG

Placebo

Placebo oral

Trial Locations (3)

80636

Deutsches Herzzentrum, Munich

81675

1. Medizinische Klinik, Klinikum rechts der Isar, Munich

Unknown

Medizinische Klinik I, Garmisch-Partenkirchen, Garmisch-Partenkirchen

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00859183 - Oral Sirolimus for In-Stent Restenosis | Biotech Hunter | Biotech Hunter